PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Environmental Health Sciences, Amherst, USA. Electronic address: edwardc@schoolph.umass.edu.\', \'7 West Melrose Avenue, Baltimore, USA.\', \'Saint Francis Hospital and Medical Center, Hartford, USA.\', \'Sri Guru Ram Das University of Health Sciences, Amritsar, India. Electronic address: drgdhawan@icloud.com.\', \'Department of Radiation Oncology, Hospital Universitario San Roque, Universidad Fernando Pessoa Canarias, Las Palmas Gran Canaria, Spain. Electronic address: pedrocarlos.lara@ulpgc.es.\', \'Departments of Neurology and Biochemistry, Georgetown University Medical Center, Washington, DC, USA. Electronic address: james.giordano@georgetown.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0167-8140(21)06208-310.1016/j.radonc.2021.04.015
?:doi
?:hasPublicationType
?:journal
  • Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
is ?:pmid of
?:pmid
?:pmid
  • 33932453
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all